Accession Number: | 0001562180-19-003124 |
Date: | 2019-05-23 |
Issuer: | ARRAY BIOPHARMA INC (ARRY) |
Original Submission Date: |
SANDOR VICTOR
C/O ARRAY BIOPHARMA INC.
3200 WALNUT STREET
BOULDER, CO 80301
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-05-23 | M | 40,634 | a | $3.65 | 278,326 | direct | ||
COMMON STOCK | 2019-05-23 | S | 40,634 | d | $26.50 | 237,692 | direct | ||
COMMON STOCK | 2019-05-28 | M | 46,766 | a | $3.65 | 284,458 | direct | ||
COMMON STOCK | 2019-05-28 | S | 74,915 | d | $27.00 | 209,543 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 3.65 | 2019-05-23 | deemed execution date | M | 40,634 (d) | 2024-09-22 | common stock 40,634 | $3.65 | 98,628 | direct | ||
STOCK OPTIONS (RIGHT TO BUY) | 3.65 | 2019-05-28 | deemed execution date | M | 46,766 (d) | 2024-09-22 | common stock 46,766 | $3.65 | 51,862 | direct |
ID | footnote |
---|---|
f1 | these trades were made pursuant to a rule 10b5-1 trading plan. |
f2 | the price reported for these shares is the weighted average sale price of transactions made at prices from $26.50 to $26.51. details of actual prices for shares sold are available from the issuer upon request. |
f3 | the price reported for these shares is the weighted average sale price of transactions made at prices from $26.75 to $27.10. details of actual prices for shares sold are available from the issuer upon request. |
f4 | the option vested in four equal annual installments beginning on september 22, 2015. |